Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis
Secondary outcomes of interest were opioid analgesic administration calculated using morphine equivalent doses of analgesia (http://www.medcalc.com/narcotics.html), the intensity of abdominal pain recorded on a scale of 1 to 10 at triage and at time of disposition, and ED length of stay. The outcome...
Gespeichert in:
Veröffentlicht in: | World journal of emergency medicine 2021-01, Vol.12 (3), p.228-231 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 231 |
---|---|
container_issue | 3 |
container_start_page | 228 |
container_title | World journal of emergency medicine |
container_volume | 12 |
creator | Schwartz, Brad E Baker, Karen Keller Bleinberger, Andrew J Lleshi, Amina Cruz-Cano, Raul |
description | Secondary outcomes of interest were opioid analgesic administration calculated using morphine equivalent doses of analgesia (http://www.medcalc.com/narcotics.html), the intensity of abdominal pain recorded on a scale of 1 to 10 at triage and at time of disposition, and ED length of stay. The outcome of reduced hospitalization rate in the IV HP group was prominent (odds ratio [OR] 0.083, 95% confidence interval [CI] 0.002-0.563, P=0.004). [14] In fact, the authors of a meta-analysis comprising 21 randomized controlled trials based on more than 3,000 patient visits calculated that cardiac dysrhythmias occurred in 0.21% of cases in which a dose of 5 mg of IV HP was administered. The study site is in a metropolitan area with a variety of secondary and tertiary hospitals, so it was possible that we did not capture all ED visits by the patients who met our inclusion criteria. |
doi_str_mv | 10.5847/wjem.j.1920-8642.2021.03.012 |
format | Article |
fullrecord | <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8188283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A667734770</galeid><wanfj_id>sjjzyxzz_e202103012</wanfj_id><sourcerecordid>sjjzyxzz_e202103012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-d48890c077276d4c3fd1900ec29e8717bdc363636dd621e1a00afdd1790da7263</originalsourceid><addsrcrecordid>eNptUk1rGzEQ3UNLE9L8h4X2UGi91ZclGUohhH4EAr20ZyFLs2stu5IryU7tX18JB7cp1RwEozdvZp5e07zGqFtKJt4_jDB3Y4dXBC0kZ6QjiOAO0Q5h8qy5POcvmuuURlSOxFwK_KK5oAwzjBi6bIY7n6Pegw-71G70FLYQnQ1T24fY5g20OYLOM_jchr51FWyyXk_Q7sPssvPDu9YczOSMnv5KaW_bQaccw1ZHSC69bJ73ekpw_XhfNT8-f_p--3Vx_-3L3e3N_cIwgfLCMilXyCAhiOCWGdpbvEIIDFlBGV2sraG8hrWcYMAaId1bi8UKWS0Ip1fNxxPvdreewRqoE09qG92s40EF7dTTF-82agh7JbGURNJC8PZE8KB9r_2gxrCLvoys0jgeD7-ORwVVaESLzAX95rFdDD93kLKaXTIwTdpDUVSRJaOMCUxxgb76B3pmJkvOJS__Rf-gBj2Bcr4PVfFKqm44F4IyIVBBdf9BlbAwOxM89K7knxR8OBWYGFKK0J8VwUhVN6nqJjWq6hpVXaPqkgpRVdf8DQsawHw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2566869203</pqid></control><display><type>article</type><title>Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis</title><source>Open Access: PubMed Central</source><source>Free E-Journal (出版社公開部分のみ)</source><creator>Schwartz, Brad E ; Baker, Karen Keller ; Bleinberger, Andrew J ; Lleshi, Amina ; Cruz-Cano, Raul</creator><creatorcontrib>Schwartz, Brad E ; Baker, Karen Keller ; Bleinberger, Andrew J ; Lleshi, Amina ; Cruz-Cano, Raul</creatorcontrib><description>Secondary outcomes of interest were opioid analgesic administration calculated using morphine equivalent doses of analgesia (http://www.medcalc.com/narcotics.html), the intensity of abdominal pain recorded on a scale of 1 to 10 at triage and at time of disposition, and ED length of stay. The outcome of reduced hospitalization rate in the IV HP group was prominent (odds ratio [OR] 0.083, 95% confidence interval [CI] 0.002-0.563, P=0.004). [14] In fact, the authors of a meta-analysis comprising 21 randomized controlled trials based on more than 3,000 patient visits calculated that cardiac dysrhythmias occurred in 0.21% of cases in which a dose of 5 mg of IV HP was administered. The study site is in a metropolitan area with a variety of secondary and tertiary hospitals, so it was possible that we did not capture all ED visits by the patients who met our inclusion criteria.</description><identifier>ISSN: 1920-8642</identifier><identifier>DOI: 10.5847/wjem.j.1920-8642.2021.03.012</identifier><identifier>PMID: 34141040</identifier><language>eng</language><publisher>Hangzhou: World Journal of Emergency Medicine</publisher><subject>Analgesics ; Droperidol ; Electrocardiography ; FDA approval ; Haloperidol ; Hospitalization ; Length of stay ; Morphine ; Narcotics ; Nausea ; Pain ; Patients ; Psychotropic drugs ; Research Letter ; Vomiting</subject><ispartof>World journal of emergency medicine, 2021-01, Vol.12 (3), p.228-231</ispartof><rights>COPYRIGHT 2021 World Journal of Emergency Medicine</rights><rights>Copyright World Journal of Emergency Medicine (WJEM) 2021</rights><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>Copyright: © World Journal of Emergency Medicine 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-d48890c077276d4c3fd1900ec29e8717bdc363636dd621e1a00afdd1790da7263</citedby><cites>FETCH-LOGICAL-c470t-d48890c077276d4c3fd1900ec29e8717bdc363636dd621e1a00afdd1790da7263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/sjjzyxzz-e/sjjzyxzz-e.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188283/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188283/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids></links><search><creatorcontrib>Schwartz, Brad E</creatorcontrib><creatorcontrib>Baker, Karen Keller</creatorcontrib><creatorcontrib>Bleinberger, Andrew J</creatorcontrib><creatorcontrib>Lleshi, Amina</creatorcontrib><creatorcontrib>Cruz-Cano, Raul</creatorcontrib><title>Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis</title><title>World journal of emergency medicine</title><description>Secondary outcomes of interest were opioid analgesic administration calculated using morphine equivalent doses of analgesia (http://www.medcalc.com/narcotics.html), the intensity of abdominal pain recorded on a scale of 1 to 10 at triage and at time of disposition, and ED length of stay. The outcome of reduced hospitalization rate in the IV HP group was prominent (odds ratio [OR] 0.083, 95% confidence interval [CI] 0.002-0.563, P=0.004). [14] In fact, the authors of a meta-analysis comprising 21 randomized controlled trials based on more than 3,000 patient visits calculated that cardiac dysrhythmias occurred in 0.21% of cases in which a dose of 5 mg of IV HP was administered. The study site is in a metropolitan area with a variety of secondary and tertiary hospitals, so it was possible that we did not capture all ED visits by the patients who met our inclusion criteria.</description><subject>Analgesics</subject><subject>Droperidol</subject><subject>Electrocardiography</subject><subject>FDA approval</subject><subject>Haloperidol</subject><subject>Hospitalization</subject><subject>Length of stay</subject><subject>Morphine</subject><subject>Narcotics</subject><subject>Nausea</subject><subject>Pain</subject><subject>Patients</subject><subject>Psychotropic drugs</subject><subject>Research Letter</subject><subject>Vomiting</subject><issn>1920-8642</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptUk1rGzEQ3UNLE9L8h4X2UGi91ZclGUohhH4EAr20ZyFLs2stu5IryU7tX18JB7cp1RwEozdvZp5e07zGqFtKJt4_jDB3Y4dXBC0kZ6QjiOAO0Q5h8qy5POcvmuuURlSOxFwK_KK5oAwzjBi6bIY7n6Pegw-71G70FLYQnQ1T24fY5g20OYLOM_jchr51FWyyXk_Q7sPssvPDu9YczOSMnv5KaW_bQaccw1ZHSC69bJ73ekpw_XhfNT8-f_p--3Vx_-3L3e3N_cIwgfLCMilXyCAhiOCWGdpbvEIIDFlBGV2sraG8hrWcYMAaId1bi8UKWS0Ip1fNxxPvdreewRqoE09qG92s40EF7dTTF-82agh7JbGURNJC8PZE8KB9r_2gxrCLvoys0jgeD7-ORwVVaESLzAX95rFdDD93kLKaXTIwTdpDUVSRJaOMCUxxgb76B3pmJkvOJS__Rf-gBj2Bcr4PVfFKqm44F4IyIVBBdf9BlbAwOxM89K7knxR8OBWYGFKK0J8VwUhVN6nqJjWq6hpVXaPqkgpRVdf8DQsawHw</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Schwartz, Brad E</creator><creator>Baker, Karen Keller</creator><creator>Bleinberger, Andrew J</creator><creator>Lleshi, Amina</creator><creator>Cruz-Cano, Raul</creator><general>World Journal of Emergency Medicine</general><general>World Journal of Emergency Medicine (WJEM)</general><general>Department of Emergency Medicine,University of Maryland Capital Region Health,UM Prince George s Hospital Center,Cheverly 20785,USA%Ross University School of Medicine Bridgetown,Bridgetown 11093,Barbados%Department of Epidemiology and Biostatistics,School of Public Health of the University of Maryland,Baltimore 21201,USA</general><general>Second Affiliated Hospital of Zhejiang University School of Medicine</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20210101</creationdate><title>Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis</title><author>Schwartz, Brad E ; Baker, Karen Keller ; Bleinberger, Andrew J ; Lleshi, Amina ; Cruz-Cano, Raul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-d48890c077276d4c3fd1900ec29e8717bdc363636dd621e1a00afdd1790da7263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analgesics</topic><topic>Droperidol</topic><topic>Electrocardiography</topic><topic>FDA approval</topic><topic>Haloperidol</topic><topic>Hospitalization</topic><topic>Length of stay</topic><topic>Morphine</topic><topic>Narcotics</topic><topic>Nausea</topic><topic>Pain</topic><topic>Patients</topic><topic>Psychotropic drugs</topic><topic>Research Letter</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartz, Brad E</creatorcontrib><creatorcontrib>Baker, Karen Keller</creatorcontrib><creatorcontrib>Bleinberger, Andrew J</creatorcontrib><creatorcontrib>Lleshi, Amina</creatorcontrib><creatorcontrib>Cruz-Cano, Raul</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>East & South Asia Database</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartz, Brad E</au><au>Baker, Karen Keller</au><au>Bleinberger, Andrew J</au><au>Lleshi, Amina</au><au>Cruz-Cano, Raul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis</atitle><jtitle>World journal of emergency medicine</jtitle><date>2021-01-01</date><risdate>2021</risdate><volume>12</volume><issue>3</issue><spage>228</spage><epage>231</epage><pages>228-231</pages><issn>1920-8642</issn><abstract>Secondary outcomes of interest were opioid analgesic administration calculated using morphine equivalent doses of analgesia (http://www.medcalc.com/narcotics.html), the intensity of abdominal pain recorded on a scale of 1 to 10 at triage and at time of disposition, and ED length of stay. The outcome of reduced hospitalization rate in the IV HP group was prominent (odds ratio [OR] 0.083, 95% confidence interval [CI] 0.002-0.563, P=0.004). [14] In fact, the authors of a meta-analysis comprising 21 randomized controlled trials based on more than 3,000 patient visits calculated that cardiac dysrhythmias occurred in 0.21% of cases in which a dose of 5 mg of IV HP was administered. The study site is in a metropolitan area with a variety of secondary and tertiary hospitals, so it was possible that we did not capture all ED visits by the patients who met our inclusion criteria.</abstract><cop>Hangzhou</cop><pub>World Journal of Emergency Medicine</pub><pmid>34141040</pmid><doi>10.5847/wjem.j.1920-8642.2021.03.012</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1920-8642 |
ispartof | World journal of emergency medicine, 2021-01, Vol.12 (3), p.228-231 |
issn | 1920-8642 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8188283 |
source | Open Access: PubMed Central; Free E-Journal (出版社公開部分のみ) |
subjects | Analgesics Droperidol Electrocardiography FDA approval Haloperidol Hospitalization Length of stay Morphine Narcotics Nausea Pain Patients Psychotropic drugs Research Letter Vomiting |
title | Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T14%3A17%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20haloperidol%20for%20the%20treatment%20of%20intractable%20vomiting,%20cyclical%20vomiting,%20and%20gastroparesis&rft.jtitle=World%20journal%20of%20emergency%20medicine&rft.au=Schwartz,%20Brad%20E&rft.date=2021-01-01&rft.volume=12&rft.issue=3&rft.spage=228&rft.epage=231&rft.pages=228-231&rft.issn=1920-8642&rft_id=info:doi/10.5847/wjem.j.1920-8642.2021.03.012&rft_dat=%3Cwanfang_jour_pubme%3Esjjzyxzz_e202103012%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2566869203&rft_id=info:pmid/34141040&rft_galeid=A667734770&rft_wanfj_id=sjjzyxzz_e202103012&rfr_iscdi=true |